Randomized Clinical Trial
Copyright ©The Author(s) 2023.
World J Gastroenterol. Apr 7, 2023; 29(13): 2034-2049
Published online Apr 7, 2023. doi: 10.3748/wjg.v29.i13.2034
Table 1 Comparison of the general information among the three groups of individuals
Indicator
TEN (n = 10)
TPN (n = 10)
SPN (n = 10)
H/F/χ2/Z/t value
P value
Age (yr, mean ± SD)59.20 ± 12.5254.30 ± 15.1059.30 ± 16.330.460.63
Sex
Male (case, %)8 (80)8 (80)8 (80)0.001.00
Female (case, %)2 (20)2 (20)2 (20)
Underlying disease
Hypertension (case, %)4 (40)3 (30)5 (50)0.830.65
Diabetes (case, %)2 (20)4 (40)2 (20)1.360.50
Malignant tumor (case, %)0 (0)2 (20)2 (20)2.300.31
APACHE II score on day 1 (points, mean ± SD)14.10 ± 2.8415.30 ± 4.7319.50 ± 7.382.120.14
SOFA score on day 1 (points, mean ± SD)5.40 ± 1.519.60 ± 1.9510.20 ± 4.105.530.10
BMI (kg/m2, mean ± SD)23.90 ± 2.7926.84 ± 3.8926.05 ± 2.671.900.17
NUTRIC score on day 1
≥ 6 points (case, %)3 (30)6 (60)6 (60)2.400.30
< 6 points (case, %)7 (70)4 (40)4 (40)
REE on day 1 [kcal, M (P25, P75)]1950.00 (1759.28, 2050.72)1900 (1726.40, 2073.59)2036 (1882.46, 2189.53)2.490.28